Literature DB >> 9773978

Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner).

W Seol1, B Hanstein, M Brown, D D Moore.   

Abstract

SHP (short heterodimer partner) is an unusual orphan receptor that lacks a conventional DNA-binding domain. Previous results have shown that it interacts with several other nuclear hormone receptors, including the retinoid and thyroid hormone receptors, and inhibits their ligand-dependent transcriptional activation. Here we show that SHP also interacts with estrogen receptors and inhibits their function. In mammalian and yeast two-hybrid systems as well as glutathione-S-transferase pull-down assays, SHP interacts specifically with estrogen receptor-alpha (ERalpha) in an agonist-dependent manner. The same assay systems using various deletion mutants of SHP map the interaction domain with ERalpha to the same SHP sequences required for interaction with the nonsteroid hormone receptors such as retinoid X receptor and thyroid hormone receptor. In transient cotransfection assays, SHP inhibits estradiol -dependent activation by ERalpha by about 5-fold. In contrast, SHP interacts with ERbeta independent of ligand and reduces its ability to activate transcription by only 50%. These data suggest that SHP functions to regulate estrogen signaling through a direct interaction with ERalpha.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773978     DOI: 10.1210/mend.12.10.0184

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  30 in total

1.  The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression.

Authors:  Y K Lee; H Dell; D H Dowhan; M Hadzopoulou-Cladaras; D D Moore
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 2.  Role of nuclear receptor SHP in metabolism and cancer.

Authors:  Yuxia Zhang; Curt H Hagedorn; Li Wang
Journal:  Biochim Biophys Acta       Date:  2010-10-20

3.  Differential modulation of transcriptional activity of oestrogen receptors by direct protein-protein interactions with retinoid receptors.

Authors:  M R Song; S K Lee; Y W Seo; H S Choi; J W Lee; M O Lee
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

4.  The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors.

Authors:  L Johansson; A Båvner; J S Thomsen; M Färnegårdh; J A Gustafsson; E Treuter
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 5.  Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation.

Authors:  Karolien De Bosscher; Sofie J Desmet; Dorien Clarisse; Eva Estébanez-Perpiña; Luc Brunsveld
Journal:  Nat Rev Endocrinol       Date:  2020-04-17       Impact factor: 43.330

6.  AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.

Authors:  Ji-Min Lee; Woo-Young Seo; Kwang-Hoon Song; Dipanjan Chanda; Yong Deuk Kim; Don-Kyu Kim; Min-Woo Lee; Dongryeol Ryu; Yong-Hoon Kim; Jung-Ran Noh; Chul-Ho Lee; John Y L Chiang; Seung-Hoi Koo; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2010-08-05       Impact factor: 5.157

7.  Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.

Authors:  Stefania Catalano; Rocco Malivindi; Cinzia Giordano; Guowei Gu; Salvatore Panza; Daniela Bonofiglio; Marilena Lanzino; Diego Sisci; Maria Luisa Panno; Sebastiano Andò
Journal:  J Biol Chem       Date:  2009-12-21       Impact factor: 5.157

8.  Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome.

Authors:  Sonya Parpart; Stephanie Roessler; Fei Dong; Vinay Rao; Atsushi Takai; Junfang Ji; Lun-Xiu Qin; Qing-Hai Ye; Hu-Liang Jia; Zhao-You Tang; Xin Wei Wang
Journal:  Hepatology       Date:  2014-07-25       Impact factor: 17.425

9.  Orphan nuclear receptor small heterodimer partner inhibits angiotensin II- stimulated PAI-1 expression in vascular smooth muscle cells.

Authors:  Kyeong-Min Lee; Hye-Young Seo; Mi-Kyung Kim; Ae-Kyung Min; Seong-Yeol Ryu; Yoon-Nyun Kim; Young Joo Park; Hueng-Sik Choi; Ki-Up Lee; Wan-Ju Park; Keun-Gyu Park; In-Kyu Lee
Journal:  Exp Mol Med       Date:  2010-01-31       Impact factor: 8.718

Review 10.  Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Authors:  Stephen Safe; Un-Ho Jin; Erik Hedrick; Alexandra Reeder; Syng-Ook Lee
Journal:  Mol Endocrinol       Date:  2013-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.